Edwards Lifesciences Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Edwards Lifesciences Corp Stock Forecast and Price Target
If the average 2024 price target of $97.00 recently set by five prominent experts for Edwards Lifesciences Corp is met, there would be a potential upside of approximately 10.21% from the last closing price in April, 2024. The high estimate is $105.00, and the low is $72.00. Even if you're not interested in EW stock, you may be interested in its competitors.
10.21% Upside
Edwards Lifesciences Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Edwards Lifesciences Corp's Price has seen a drop from $70.27 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $124.30 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$337.15 | Buy/Sell | $353.16 | 8.71% |
| ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$119.75 | Buy/Sell | $132.52 | 13.57% |
| MSA Stock Forecast | MSA Safety | Outperform |
18
|
$188.71 | Buy/Sell | $192.50 | 1.21% |
| ENOV Stock Forecast | Enovis | Buy |
15
|
$55.10 | Buy/Sell | $70.50 | 36.12% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$28.41 | Buy/Sell | $46.60 | 53.12% |
Edwards Lifesciences Corp Revenue Forecast for 2023 - 2025 - 2030
Edwards Lifesciences Corp's Revenue has seen growth In the last three years, going from $4.39B to $6.00B – a gain of 36.90% In the next year, analysts believe that Revenue will reach $7.19B – an increase of 19.76%. For the next seven years, the forecast is forRevenue to grow by 107.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATEC Stock Forecast | Alphatec Holdings | Buy |
7
|
$12.24 | Buy/Sell | $21.85 | 87.91% |
| XENT Stock Forecast | Intersect ENT | - |
6
|
$28.24 | Buy/Sell | $28.25 | -100.00% |
| AVNS Stock Forecast | Avanos Medical | Hold |
11
|
$17.85 | Buy/Sell | $23.50 | 31.65% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYRX Stock Forecast | Cryoport | Outperform |
8
|
$16.03 | Buy/Sell | $17.61 | 12.29% |
| AORT Stock Forecast | Artivion | Buy |
12
|
$20.27 | Buy/Sell | $24.15 | 23.33% |
| SIBN Stock Forecast | SI-BONE | Buy |
6
|
$14.27 | Buy/Sell | $25.63 | 82.20% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KIDS Stock Forecast | OrthoPediatrics | Outperform |
7
|
$29.94 | Buy/Sell | $41.17 | 28.59% |
| AXGN Stock Forecast | AxoGen | Buy |
6
|
$6.52 | Buy/Sell | $12.50 | 114.72% |
| SMTI Stock Forecast | Sanara MedTech | Buy |
11
|
$32.21 | Buy/Sell | $49.00 | 36.60% |
Edwards Lifesciences Corp EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Edwards Lifesciences Corp's EBITDA has increased by 31.71%, going from $1.42B to $1.87B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $2.56B – an increase of 36.48%. The Edwards Lifesciences Corp forecast is for EBITDA to reach $4.86B or grow by 159.40%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IIN Stock Forecast | IntriCon | - |
10
|
$0.00 | Buy/Sell | $25.00 | 0.00% |
| SPNE Stock Forecast | SeaSpine Holdings | - |
8
|
$9.54 | Buy/Sell | $16.10 | -100.00% |
| LAKE Stock Forecast | Lakeland Industries | Outperform |
16
|
$16.69 | Buy/Sell | $21.50 | 28.82% |
Edwards Lifesciences Corp EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Edwards Lifesciences Corp's EBIT has grown, increasing from $1.32B to $1.73B – an increase of 31.42%. For next year, the 14 analysts predict EBIT of $2.35B, which would mean an increase of 36.11%. Over the next seven years, the pros' prediction is EBITof $4.66B, which would mean a seven-year growth forecast of 169.34%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CFMS Stock Forecast | Conformis | - |
0
|
$1.55 | Buy/Sell | $2.33 | -100.00% |
| UEEC Stock Forecast | United Health Products | - |
2
|
$0.18 | Buy/Sell | $0.30 | -100.00% |
| RMTI Stock Forecast | Rockwell Medical | Outperform |
7
|
$1.35 | Buy/Sell | $8.00 | 492.59% |
Edwards Lifesciences Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Edwards Lifesciences Corp's EPS has seen a drop from $1.86 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $3.29 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SRGA.Q Stock Forecast | Surgalign Holdings | - |
8
|
$0.01 | Buy/Sell | $3.36 | -100.00% |
| IVC Stock Forecast | Invacare | - |
12
|
$0.02 | Buy/Sell | $1.30 | -100.00% |
| VPRB Stock Forecast | VPR Brands, LP | - |
-13
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
Site Navigation
.jpg)